Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4024257017 | Brentuximab vedotin-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
4024258010 | Product containing brentuximab vedotin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Brentuximab vedotin-containing product in parenteral dose form | Is a | Brentuximab vedotin-containing product | true | Inferred relationship | Some | ||
Brentuximab vedotin-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
Brentuximab vedotin-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Brentuximab vedotin-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
Brentuximab vedotin-containing product in parenteral dose form | Has active ingredient | Brentuximab vedotin | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Brentuximab vedotin only product in parenteral dose form | Is a | True | Brentuximab vedotin-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets